CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Gift Chief Scientist gave 210,000 shares (gift)
- 424B3 Offering Prospectus
- 4 Open-market buy Director bought 200,000 shares at $5.36 ($1,072,000)
- 4 Open-market buy CEO, President, and Secretary bought 250,000 shares at an average $4.72 ($1,181,176)
- 4 Open-market buy Director bought 50,000 shares at an average $4.51 ($225,505)
- 4 Open-market buy CFO and Treasurer bought 15,000 shares at $4.58 ($68,633)
- 4 Open-market buy Director bought 100,000 shares at $5.30 ($529,890)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 36,970 shares at an average $7.71 ($285,041)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy CFO and Treasurer bought 17,500 shares at $7.71 ($134,925)
- 4 Open-market buy General Counsel bought 5,000 shares at $7.56 ($37,807)
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
Page 12 of 17 · 328 filings